We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current WED market cap is 4.43B. The company's latest EPS is USD 1.3964 and P/E is 23.87.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.4M | 950k | 5.06M | 950k | 473k |
| Operating Income | -3.72M | -4.72M | 8.72M | -5.6M | -23.07M |
| Net Income | 8.52M | -34.4M | 28.21M | 17.96M | 183.98M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 410.75M | 377.35M | 401.66M | 413.29M | 551.82M |
| Total Liabilities | 56.08M | 56.83M | 53.98M | 50.22M | 33.48M |
| Total Equity | 354.67M | 320.52M | 347.68M | 363.07M | 518.35M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 1.35M | 18.54M | -5.12M | -2.46M | -3.09M |
| Investing | 13.06M | -32.04M | 3.99M | 1.9M | 198.89M |
| Financing | N/A | N/A | -1.06M | -2.56M | -64.2M |
| Market Cap | 4.43B |
| Price to Earnings Ratio | 23.87 |
| Price to Sales Ratio | 9.26k |
| Price to Cash Ratio | 32.52 |
| Price to Book Ratio | 8.47 |
| Dividend Yield | - |
| Shares Outstanding | 131.76M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.24 (0.71%) |
| Company Name | Westaim Corporation |
| Address |
70 york street, suite 1700 toronto, ontario M5J 1S9 |
| Website | https://www.westaim.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
